Pharma funds have been topping the return charts since the Covid-19 pandemic hit the world. The category that invests mostly in the pharmaceutical sector has offered 58.16% returns in one year and 48.25% returns in this year to date, according to Value Research, a mutual fund tracking firm. Among the pharma funds, DSP Healthcare Fund is ahead of others in the return charts with 71.4% returns in one year.The fund was launched in 2018 and it
